471 Neb. Admin. Code, ch. 16, § 002

Current through June 17, 2024

Section 471-16-002 - DRUG UTILIZATION REVIEW

As a condition of participation, the provider is required to:

(A) Provide prospective drug utilization review before dispensing each prescription. This includes screening for:

(i) Therapeutic duplication:

(ii) Drug disease contraindications:

(iii) Drug interactions:

(iv) Incorrect dosage or duration:

(v) Drug allergies: and

(vi) Clinical abuse and misuse:

(B) Provide patient counseling on all matters which, in the provider's professional judgment are deemed significant, including:

(i) Name and description of the medication:

(ii) Route, dosage form, duration of therapy;

(iii) Directions for use;

(iv) Adverse reactions, contraindications:

(v) Storage: and

(vi) Refill information: and

(C) Maintain adequate patient profiles which may include:

(i) Name, address, phone number, date of birth, and gender;

(ii) individual history;

(iii) Comprehensive listing of medications: and

(iv) Relevant comments.

471 Neb. Admin. Code, ch. 16, § 002

Amended effective 7/2/2017.

Amended effective 12/26/2021